3D QSAR methods: Phase and catalyst compared

被引:62
作者
Evans, David A.
Doman, Thompson N.
Thorner, David A.
Bodkin, Michael J.
机构
[1] Eli Lilly & Co Ltd, Lilly Res Ctr, Surrey GU20 6PH, England
[2] Eli Lilly & Co, Lilly Corp Ctr, Lilly Corp Ctr, Indianapolis, IN 46285 USA
关键词
D O I
10.1021/ci7000082
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The programs Phase and Catalyst HypoGen are compared for their performance in determining three-dimensional quantitative structure-activity relationships. Eight sets of compounds with measured activity were collected from the public literature and partitioned into suitable training and test sets by an automated procedure. A range of models is built with each program, and suggested parameter variations are investigated. The models are assessed by their ability to predict the activity of compounds in the test set, and it is demonstrated that the performance of Phase is better than or equal to that of Catalyst HypoGen, with the data sets and parameters used here. Additionally, compounds in two of the data sets are overlaid on crystallographic structures of similar ligands in complex with the target receptor, in order to guide pharmacophore generation by the two programs, but the resulting models do not perform better.
引用
收藏
页码:1248 / 1257
页数:10
相关论文
共 46 条
[1]  
*ACC INC, 2006, CAT VERS 4 11
[2]  
[Anonymous], 2000, PHARMACOPHORE PERCEP
[3]   Identification of common functional configurations among molecules [J].
Barnum, D ;
Greene, J ;
Smellie, A ;
Sprague, P .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 1996, 36 (03) :563-571
[4]   Reproducing the conformations of protein-bound ligands:: A critical evaluation of several popular conformational searching tools [J].
Boström, J .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2001, 15 (12) :1137-1152
[5]   The first potent inhibitors for human glutaminyl cyclase: Synthesis and structure-activity relationship [J].
Buchholz, M ;
Heiser, U ;
Schilling, S ;
Niestroj, AJ ;
Zunkel, K ;
Demuth, HU .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (02) :664-677
[6]   Molecular design based on 3D-pharmacophore.: Application to 5-HT4 receptor [J].
Bureau, R ;
Daveu, C ;
Lemaître, SP ;
Dauphin, F ;
Landelle, H ;
Lancelot, JC ;
Rault, S .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2002, 42 (04) :962-967
[7]  
*CHEM COMP GROUP I, 2006, MOE
[8]  
*CHEM LTD, 2005, MOLC VERS 4 0 4
[9]  
Chen X, 2001, COMB CHEM HIGH T SCR, V4, P719
[10]   What has computer-aided molecular design ever done for drug discovery? [J].
Clark, David E. .
EXPERT OPINION ON DRUG DISCOVERY, 2006, 1 (02) :103-110